Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 9.74422866 |
2 | negative thymic T cell selection (GO:0045060) | 8.77544455 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.51971267 |
4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.61396191 |
5 | positive T cell selection (GO:0043368) | 7.56225754 |
6 | thymic T cell selection (GO:0045061) | 7.31871545 |
7 | T cell selection (GO:0045058) | 7.29727602 |
8 | negative regulation of cell killing (GO:0031342) | 7.26631609 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.26631609 |
10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 7.04925012 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.00386861 |
12 | positive thymic T cell selection (GO:0045059) | 6.76408541 |
13 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.62978294 |
14 | interferon-gamma production (GO:0032609) | 6.55664500 |
15 | regulation of T cell tolerance induction (GO:0002664) | 6.55112451 |
16 | T cell receptor signaling pathway (GO:0050852) | 6.39407487 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.29012987 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.29012987 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 6.27408550 |
20 | response to interleukin-15 (GO:0070672) | 5.81368298 |
21 | T cell costimulation (GO:0031295) | 5.67856091 |
22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.64848816 |
23 | cellular response to interleukin-15 (GO:0071350) | 5.58425102 |
24 | lymphocyte costimulation (GO:0031294) | 5.57803168 |
25 | pyrimidine nucleoside catabolic process (GO:0046135) | 5.44696748 |
26 | positive regulation of tolerance induction (GO:0002645) | 5.34573397 |
27 | T cell migration (GO:0072678) | 5.26995011 |
28 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.25989090 |
29 | antigen receptor-mediated signaling pathway (GO:0050851) | 5.25030103 |
30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21102383 |
31 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.16205123 |
32 | V(D)J recombination (GO:0033151) | 5.13124958 |
33 | leukocyte aggregation (GO:0070486) | 5.12730134 |
34 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.12629004 |
35 | positive regulation of B cell differentiation (GO:0045579) | 5.08731838 |
36 | actin nucleation (GO:0045010) | 5.05019875 |
37 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.89576297 |
38 | ribosomal small subunit assembly (GO:0000028) | 4.86672975 |
39 | negative regulation of T cell apoptotic process (GO:0070233) | 4.82066664 |
40 | activated T cell proliferation (GO:0050798) | 4.81574762 |
41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.75238555 |
42 | negative regulation of viral genome replication (GO:0045071) | 4.74446818 |
43 | mast cell activation (GO:0045576) | 4.68819251 |
44 | regulation of tolerance induction (GO:0002643) | 4.68664611 |
45 | positive regulation of interleukin-2 production (GO:0032743) | 4.57189016 |
46 | regulation of B cell differentiation (GO:0045577) | 4.45727472 |
47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.38883957 |
48 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.34433252 |
49 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.27526604 |
50 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.27526604 |
51 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.23424760 |
52 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.23424760 |
53 | negative regulation of T cell mediated immunity (GO:0002710) | 4.19248249 |
54 | T cell differentiation (GO:0030217) | 4.12665758 |
55 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.03640040 |
56 | positive regulation of isotype switching (GO:0045830) | 4.01991263 |
57 | negative regulation by host of viral transcription (GO:0043922) | 4.00501661 |
58 | alpha-beta T cell differentiation (GO:0046632) | 3.99638512 |
59 | positive regulation of humoral immune response (GO:0002922) | 3.95854665 |
60 | alpha-beta T cell activation (GO:0046631) | 3.93873723 |
61 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.90068958 |
62 | positive regulation of B cell mediated immunity (GO:0002714) | 3.90068958 |
63 | signal complex assembly (GO:0007172) | 3.88718177 |
64 | cytolysis (GO:0019835) | 3.88359837 |
65 | cellular response to interleukin-4 (GO:0071353) | 3.83488275 |
66 | macrophage chemotaxis (GO:0048246) | 3.81078760 |
67 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.77902317 |
68 | regulation of isotype switching (GO:0045191) | 3.73193836 |
69 | regulation of regulatory T cell differentiation (GO:0045589) | 3.72026630 |
70 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.72025841 |
71 | T cell activation (GO:0042110) | 3.71038140 |
72 | regulation of defense response to virus by virus (GO:0050690) | 3.66419894 |
73 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.62491066 |
74 | sequestering of actin monomers (GO:0042989) | 3.61282183 |
75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.59938408 |
76 | mast cell degranulation (GO:0043303) | 3.57520469 |
77 | mast cell activation involved in immune response (GO:0002279) | 3.57520469 |
78 | lymphocyte chemotaxis (GO:0048247) | 3.56934356 |
79 | eosinophil chemotaxis (GO:0048245) | 3.56332395 |
80 | positive regulation of immunoglobulin production (GO:0002639) | 3.56152717 |
81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.52946240 |
82 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.51536709 |
83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.51201828 |
84 | regulation of B cell mediated immunity (GO:0002712) | 3.50090477 |
85 | positive regulation of DNA recombination (GO:0045911) | 3.47106686 |
86 | response to interleukin-4 (GO:0070670) | 3.45957506 |
87 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.43337436 |
88 | regulation of immunoglobulin production (GO:0002637) | 3.42731198 |
89 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.42324726 |
90 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.40755452 |
91 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.38628993 |
92 | immunoglobulin mediated immune response (GO:0016064) | 3.38408942 |
93 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.38389086 |
94 | regulation of interleukin-2 production (GO:0032663) | 3.37375079 |
95 | regulation of interleukin-8 secretion (GO:2000482) | 3.34522491 |
96 | regulation of viral genome replication (GO:0045069) | 3.34402774 |
97 | positive regulation of granulocyte differentiation (GO:0030854) | 3.32406479 |
98 | viral transcription (GO:0019083) | 3.31441013 |
99 | regulation of interleukin-4 production (GO:0032673) | 3.27380003 |
100 | T cell homeostasis (GO:0043029) | 3.27220445 |
101 | positive regulation of interleukin-4 production (GO:0032753) | 3.26551192 |
102 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.25928607 |
103 | eosinophil migration (GO:0072677) | 3.24990473 |
104 | regulation of cell killing (GO:0031341) | 3.23965966 |
105 | regulation of response to interferon-gamma (GO:0060330) | 3.23067287 |
106 | positive regulation of cell killing (GO:0031343) | 3.22760910 |
107 | positive regulation of immune response to tumor cell (GO:0002839) | 3.22696459 |
108 | regulation of immune response to tumor cell (GO:0002837) | 3.22696459 |
109 | regulation of response to tumor cell (GO:0002834) | 3.22696459 |
110 | positive regulation of response to tumor cell (GO:0002836) | 3.22696459 |
111 | positive regulation of T cell activation (GO:0050870) | 3.18814139 |
112 | leukocyte cell-cell adhesion (GO:0007159) | 3.18101925 |
113 | cellular defense response (GO:0006968) | 3.17820158 |
114 | lymphocyte migration (GO:0072676) | 3.17104209 |
115 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.16606840 |
116 | T cell proliferation (GO:0042098) | 3.16449715 |
117 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.14597230 |
118 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14482606 |
119 | regulation of activation of Janus kinase activity (GO:0010533) | 3.14320554 |
120 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.14096169 |
121 | translational termination (GO:0006415) | 3.13147820 |
122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12330999 |
123 | ribosomal small subunit biogenesis (GO:0042274) | 3.10387203 |
124 | positive regulation of T cell cytokine production (GO:0002726) | 3.10017743 |
125 | regulation of calcium-mediated signaling (GO:0050848) | 3.09637232 |
126 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.08533995 |
127 | regulation of T cell apoptotic process (GO:0070232) | 3.05475452 |
128 | response to interferon-beta (GO:0035456) | 3.05174602 |
129 | positive regulation of defense response to virus by host (GO:0002230) | 3.05009394 |
130 | regulation of chronic inflammatory response (GO:0002676) | 3.04193498 |
131 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.03250301 |
132 | negative regulation of viral process (GO:0048525) | 3.02210088 |
133 | heterotypic cell-cell adhesion (GO:0034113) | 2.98955776 |
134 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.98438298 |
135 | positive regulation of lymphocyte migration (GO:2000403) | 2.97683960 |
136 | negative regulation of stress fiber assembly (GO:0051497) | 2.94848649 |
137 | positive regulation of lamellipodium assembly (GO:0010592) | 2.94544365 |
138 | DNA demethylation (GO:0080111) | 2.94006754 |
139 | chemokine-mediated signaling pathway (GO:0070098) | 2.91482651 |
140 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.91150916 |
141 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.87611822 |
142 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.86537457 |
143 | cytidine deamination (GO:0009972) | 11.2615086 |
144 | cytidine metabolic process (GO:0046087) | 11.2615086 |
145 | cytidine catabolic process (GO:0006216) | 11.2615086 |
146 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.6727725 |
147 | DNA deamination (GO:0045006) | 10.2117086 |
148 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 10.1382408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.78197745 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.34596305 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.12479463 |
4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.97267714 |
5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.76267737 |
6 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.76019127 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 3.73552655 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71810501 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.39585333 |
10 | MYB_26560356_Chip-Seq_TH2_Human | 3.33449657 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.30256974 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.27603424 |
13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.02804725 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.96023013 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87595253 |
16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.83354498 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69010463 |
18 | MYB_26560356_Chip-Seq_TH1_Human | 2.61992651 |
19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.35703091 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34095809 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29077801 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14096281 |
23 | MAF_26560356_Chip-Seq_TH2_Human | 2.10974999 |
24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07674234 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03867446 |
26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01774323 |
27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99288492 |
28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83501951 |
29 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.82596932 |
30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82149573 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80906624 |
32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79899521 |
33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74732642 |
34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74371053 |
35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74329403 |
36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.73310359 |
37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70289454 |
38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69774701 |
39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69179659 |
40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64795495 |
41 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.61636376 |
42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60844750 |
43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56512149 |
44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56232763 |
45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55739816 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51890678 |
47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51698958 |
48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50621464 |
49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50009471 |
50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49106711 |
51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47143148 |
52 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46748924 |
53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.39734706 |
54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39130366 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38555484 |
56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37915079 |
57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33009768 |
58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32732569 |
59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32200588 |
60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31128667 |
61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30983164 |
62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30127442 |
63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29918042 |
64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28494215 |
65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27490468 |
66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25962777 |
67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23646712 |
68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21215776 |
69 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.18707512 |
70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17901025 |
71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16108113 |
72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15868162 |
73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15355439 |
74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14366550 |
75 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.13412064 |
76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12389059 |
77 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07678378 |
78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07181136 |
79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07144144 |
80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06196266 |
81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05281088 |
82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04097402 |
83 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01900664 |
84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00080649 |
85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98627843 |
86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98615212 |
87 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97529008 |
88 | P300_27268052_Chip-Seq_Bcells_Human | 0.97520876 |
89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96351226 |
90 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95917865 |
91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95193221 |
92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95090263 |
93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95074240 |
94 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93796547 |
95 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93388912 |
96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92783870 |
97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92583289 |
98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92377434 |
99 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92262701 |
100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91448044 |
101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90603608 |
102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88931350 |
103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88874800 |
104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87927142 |
105 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87900701 |
106 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87888022 |
107 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87498449 |
108 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87335242 |
109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87335242 |
110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87149905 |
111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87022204 |
112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86571531 |
113 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.85731809 |
114 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85325976 |
115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85113050 |
116 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.84687671 |
117 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84445165 |
118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83998682 |
119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83946240 |
120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83628284 |
121 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82654146 |
122 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82473981 |
123 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80167641 |
124 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.79317372 |
125 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78916271 |
126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77878587 |
127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.77392431 |
128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77116402 |
129 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.76522739 |
130 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.75706348 |
131 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75617606 |
132 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.74158339 |
133 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.73366741 |
134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73186750 |
135 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73170445 |
136 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.73051824 |
137 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.71866421 |
138 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.71766136 |
139 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71395764 |
140 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.70475342 |
141 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.70047501 |
142 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69891728 |
143 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.69580019 |
144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69056589 |
145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67894920 |
146 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.67747265 |
147 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.66755345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 6.66508607 |
2 | MP0005671_abnormal_response_to | 5.05847646 |
3 | MP0000685_abnormal_immune_system | 3.79321868 |
4 | MP0009333_abnormal_splenocyte_physiolog | 3.46022098 |
5 | MP0000703_abnormal_thymus_morphology | 3.42260163 |
6 | MP0001835_abnormal_antigen_presentation | 3.23079155 |
7 | MP0002166_altered_tumor_susceptibility | 3.20004442 |
8 | MP0001800_abnormal_humoral_immune | 3.19321606 |
9 | MP0002398_abnormal_bone_marrow | 3.17486008 |
10 | MP0002420_abnormal_adaptive_immunity | 3.00440725 |
11 | MP0001819_abnormal_immune_cell | 2.94919504 |
12 | MP0005000_abnormal_immune_tolerance | 2.83873331 |
13 | MP0002723_abnormal_immune_serum | 2.76897524 |
14 | MP0000716_abnormal_immune_system | 2.69043381 |
15 | MP0002722_abnormal_immune_system | 2.65195094 |
16 | MP0002006_tumorigenesis | 2.59248412 |
17 | MP0005387_immune_system_phenotype | 2.58724847 |
18 | MP0001790_abnormal_immune_system | 2.58724847 |
19 | MP0002452_abnormal_antigen_presenting | 2.50601778 |
20 | MP0002405_respiratory_system_inflammati | 2.47475956 |
21 | MP0000689_abnormal_spleen_morphology | 2.46006271 |
22 | MP0005025_abnormal_response_to | 2.35854203 |
23 | MP0009785_altered_susceptibility_to | 2.34747757 |
24 | MP0002396_abnormal_hematopoietic_system | 2.25025838 |
25 | MP0002429_abnormal_blood_cell | 2.18185037 |
26 | MP0003436_decreased_susceptibility_to | 2.17458541 |
27 | MP0004947_skin_inflammation | 2.17062609 |
28 | MP0003300_gastrointestinal_ulcer | 2.11557123 |
29 | MP0004381_abnormal_hair_follicle | 2.11410405 |
30 | MP0010155_abnormal_intestine_physiology | 2.04970885 |
31 | MP0006082_CNS_inflammation | 2.02277212 |
32 | MP0002148_abnormal_hypersensitivity_rea | 1.93058055 |
33 | MP0003724_increased_susceptibility_to | 1.88640902 |
34 | MP0001873_stomach_inflammation | 1.87009629 |
35 | MP0003866_abnormal_defecation | 1.86840554 |
36 | MP0002933_joint_inflammation | 1.85469106 |
37 | MP0003646_muscle_fatigue | 1.84602902 |
38 | MP0002419_abnormal_innate_immunity | 1.71021964 |
39 | MP0005464_abnormal_platelet_physiology | 1.67516969 |
40 | MP0001845_abnormal_inflammatory_respons | 1.63997701 |
41 | MP0000858_altered_metastatic_potential | 1.56529368 |
42 | MP0004808_abnormal_hematopoietic_stem | 1.45011998 |
43 | MP0002102_abnormal_ear_morphology | 1.41322561 |
44 | MP0005075_abnormal_melanosome_morpholog | 1.36828638 |
45 | MP0001853_heart_inflammation | 1.32949229 |
46 | MP0006054_spinal_hemorrhage | 1.32507945 |
47 | MP0000372_irregular_coat_pigmentation | 1.31581680 |
48 | MP0008872_abnormal_physiological_respon | 1.30232908 |
49 | MP0003448_altered_tumor_morphology | 1.25326246 |
50 | MP0000465_gastrointestinal_hemorrhage | 1.24413073 |
51 | MP0002009_preneoplasia | 1.22770009 |
52 | MP0001919_abnormal_reproductive_system | 1.21195021 |
53 | MP0003786_premature_aging | 1.20677302 |
54 | MP0004145_abnormal_muscle_electrophysio | 1.18203539 |
55 | MP0008995_early_reproductive_senescence | 1.17268623 |
56 | MP0002019_abnormal_tumor_incidence | 1.16846387 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.12620294 |
58 | MP0003303_peritoneal_inflammation | 1.12009948 |
59 | MP0003137_abnormal_impulse_conducting | 1.07886490 |
60 | MP0002132_abnormal_respiratory_system | 1.06851481 |
61 | MP0010094_abnormal_chromosome_stability | 1.03977362 |
62 | MP0008057_abnormal_DNA_replication | 1.03278221 |
63 | MP0001545_abnormal_hematopoietic_system | 1.01940637 |
64 | MP0005397_hematopoietic_system_phenotyp | 1.01940637 |
65 | MP0005645_abnormal_hypothalamus_physiol | 0.99844731 |
66 | MP0002277_abnormal_respiratory_mucosa | 0.98774903 |
67 | MP0004957_abnormal_blastocyst_morpholog | 0.98670536 |
68 | MP0000490_abnormal_crypts_of | 0.98061710 |
69 | MP0005377_hearing/vestibular/ear_phenot | 0.97898701 |
70 | MP0003878_abnormal_ear_physiology | 0.97898701 |
71 | MP0005360_urolithiasis | 0.93661524 |
72 | MP0009379_abnormal_foot_pigmentation | 0.92154876 |
73 | MP0008469_abnormal_protein_level | 0.91898705 |
74 | MP0005023_abnormal_wound_healing | 0.89586092 |
75 | MP0003077_abnormal_cell_cycle | 0.89342114 |
76 | MP0001533_abnormal_skeleton_physiology | 0.86147268 |
77 | MP0005166_decreased_susceptibility_to | 0.83243913 |
78 | MP0004510_myositis | 0.81855124 |
79 | MP0005310_abnormal_salivary_gland | 0.78563613 |
80 | MP0003075_altered_response_to | 0.77255543 |
81 | MP0001485_abnormal_pinna_reflex | 0.76815814 |
82 | MP0001905_abnormal_dopamine_level | 0.76588983 |
83 | MP0006072_abnormal_retinal_apoptosis | 0.75960183 |
84 | MP0008961_abnormal_basal_metabolism | 0.75588913 |
85 | MP0005389_reproductive_system_phenotype | 0.75079828 |
86 | MP0003045_fibrosis | 0.72353708 |
87 | MP0001542_abnormal_bone_strength | 0.71965649 |
88 | MP0001851_eye_inflammation | 0.71059394 |
89 | MP0001348_abnormal_lacrimal_gland | 0.70103094 |
90 | MP0009765_abnormal_xenobiotic_induced | 0.68087984 |
91 | MP0002998_abnormal_bone_remodeling | 0.67018017 |
92 | MP0001243_abnormal_dermal_layer | 0.66937969 |
93 | MP0009763_increased_sensitivity_to | 0.65687187 |
94 | MP0008877_abnormal_DNA_methylation | 0.64215133 |
95 | MP0001986_abnormal_taste_sensitivity | 0.63296413 |
96 | MP0005636_abnormal_mineral_homeostasis | 0.61650296 |
97 | MP0005410_abnormal_fertilization | 0.61222459 |
98 | MP0005076_abnormal_cell_differentiation | 0.60245883 |
99 | MP0009697_abnormal_copulation | 0.59175655 |
100 | MP0010386_abnormal_urinary_bladder | 0.58818998 |
101 | MP0005379_endocrine/exocrine_gland_phen | 0.58717308 |
102 | MP0004185_abnormal_adipocyte_glucose | 0.58369442 |
103 | MP0005257_abnormal_intraocular_pressure | 0.57878066 |
104 | MP0003693_abnormal_embryo_hatching | 0.57647748 |
105 | MP0001968_abnormal_touch/_nociception | 0.57522524 |
106 | MP0001765_abnormal_ion_homeostasis | 0.57442823 |
107 | MP0002876_abnormal_thyroid_physiology | 0.57009976 |
108 | MP0010234_abnormal_vibrissa_follicle | 0.56615869 |
109 | MP0003252_abnormal_bile_duct | 0.56002796 |
110 | MP0009278_abnormal_bone_marrow | 0.55352823 |
111 | MP0000609_abnormal_liver_physiology | 0.55266422 |
112 | MP0000639_abnormal_adrenal_gland | 0.55028629 |
113 | MP0000477_abnormal_intestine_morphology | 0.54630481 |
114 | MP0008007_abnormal_cellular_replicative | 0.52932397 |
115 | MP0009643_abnormal_urine_homeostasis | 0.51794815 |
116 | MP0005551_abnormal_eye_electrophysiolog | 0.51594207 |
117 | MP0003795_abnormal_bone_structure | 0.50233977 |
118 | MP0002163_abnormal_gland_morphology | 0.50214911 |
119 | MP0005330_cardiomyopathy | 0.50183209 |
120 | MP0002736_abnormal_nociception_after | 0.49919859 |
121 | MP0000350_abnormal_cell_proliferation | 0.49153906 |
122 | MP0001663_abnormal_digestive_system | 0.49138176 |
123 | MP0008058_abnormal_DNA_repair | 0.49023580 |
124 | MP0009764_decreased_sensitivity_to | 0.48871054 |
125 | MP0001191_abnormal_skin_condition | 0.48745783 |
126 | MP0002693_abnormal_pancreas_physiology | 0.48267120 |
127 | MP0000920_abnormal_myelination | 0.48143891 |
128 | MP0005174_abnormal_tail_pigmentation | 0.48057098 |
129 | MP0008873_increased_physiological_sensi | 0.46898315 |
130 | MP0002822_catalepsy | 0.46778609 |
131 | MP0003453_abnormal_keratinocyte_physiol | 0.45827468 |
132 | MP0002136_abnormal_kidney_physiology | 0.44641778 |
133 | MP0008569_lethality_at_weaning | 0.44537478 |
134 | MP0000367_abnormal_coat/_hair | 0.44522205 |
135 | MP0002095_abnormal_skin_pigmentation | 0.43751961 |
136 | MP0002083_premature_death | 0.42147421 |
137 | MP0001216_abnormal_epidermal_layer | 0.41898478 |
138 | MP0000604_amyloidosis | 0.40755163 |
139 | MP0003111_abnormal_nucleus_morphology | 0.39776188 |
140 | MP0000313_abnormal_cell_death | 0.39269383 |
141 | MP0008770_decreased_survivor_rate | 0.38702358 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of T cell number (HP:0011839) | 9.65595540 |
2 | Aplastic anemia (HP:0001915) | 7.64550819 |
3 | Severe combined immunodeficiency (HP:0004430) | 6.53276223 |
4 | Combined immunodeficiency (HP:0005387) | 6.43767646 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.20869957 |
6 | Abnormality of T cells (HP:0002843) | 5.92583751 |
7 | Recurrent viral infections (HP:0004429) | 5.30605838 |
8 | Eosinophilia (HP:0001880) | 5.29164309 |
9 | IgG deficiency (HP:0004315) | 4.99119200 |
10 | Abnormality of eosinophils (HP:0001879) | 4.94431716 |
11 | Panhypogammaglobulinemia (HP:0003139) | 4.82603418 |
12 | Stomatitis (HP:0010280) | 4.79383501 |
13 | Thyroiditis (HP:0100646) | 4.71285204 |
14 | B lymphocytopenia (HP:0010976) | 4.49867237 |
15 | Abnormality of B cell number (HP:0010975) | 4.49867237 |
16 | Granulocytopenia (HP:0001913) | 4.43899593 |
17 | Recurrent fungal infections (HP:0002841) | 4.34616571 |
18 | Hypoplasia of the thymus (HP:0000778) | 4.23223041 |
19 | Leukocytosis (HP:0001974) | 4.14703816 |
20 | Chronic otitis media (HP:0000389) | 4.14096578 |
21 | Recurrent bronchitis (HP:0002837) | 4.10864645 |
22 | Myositis (HP:0100614) | 3.92130341 |
23 | Increased IgM level (HP:0003496) | 3.90886832 |
24 | Congenital stationary night blindness (HP:0007642) | 3.90660777 |
25 | Autoimmune hemolytic anemia (HP:0001890) | 3.86542608 |
26 | Joint swelling (HP:0001386) | 3.76939928 |
27 | Nasal polyposis (HP:0100582) | 3.71029822 |
28 | Abnormality of macrophages (HP:0004311) | 3.69452765 |
29 | Pustule (HP:0200039) | 3.61799998 |
30 | IgM deficiency (HP:0002850) | 3.27560718 |
31 | Lymphopenia (HP:0001888) | 3.27068406 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19021531 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19021531 |
34 | Thrombocytosis (HP:0001894) | 3.18176437 |
35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.17335836 |
36 | Chronic diarrhea (HP:0002028) | 3.08322262 |
37 | Abnormality of the nasal mucosa (HP:0000433) | 3.07392683 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07391755 |
39 | Autoimmune thrombocytopenia (HP:0001973) | 3.02217174 |
40 | Encephalitis (HP:0002383) | 2.98928766 |
41 | Eczematoid dermatitis (HP:0000976) | 2.95999633 |
42 | Abnormality of the fingertips (HP:0001211) | 2.95934135 |
43 | Abnormality of the prostate (HP:0008775) | 2.90813398 |
44 | Meningitis (HP:0001287) | 2.88553453 |
45 | Lymphoma (HP:0002665) | 2.80553321 |
46 | Spontaneous hematomas (HP:0007420) | 2.73843417 |
47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69045153 |
48 | Basal cell carcinoma (HP:0002671) | 2.68053898 |
49 | Abnormality of T cell physiology (HP:0011840) | 2.66518824 |
50 | Hypergammaglobulinemia (HP:0010702) | 2.62894525 |
51 | Papilloma (HP:0012740) | 2.62590521 |
52 | Verrucae (HP:0200043) | 2.62590521 |
53 | Gangrene (HP:0100758) | 2.57348368 |
54 | Gastrointestinal infarctions (HP:0005244) | 2.49119197 |
55 | Increased intramyocellular lipid droplets (HP:0012240) | 2.48852040 |
56 | Oral leukoplakia (HP:0002745) | 2.48162182 |
57 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.48099081 |
58 | Recurrent otitis media (HP:0000403) | 2.47011871 |
59 | Recurrent abscess formation (HP:0002722) | 2.43325803 |
60 | Mitochondrial inheritance (HP:0001427) | 2.43104787 |
61 | Pancytopenia (HP:0001876) | 2.41958662 |
62 | Keratoconjunctivitis sicca (HP:0001097) | 2.34896339 |
63 | Bronchitis (HP:0012387) | 2.33097040 |
64 | Abnormal platelet volume (HP:0011876) | 2.32362778 |
65 | Pigmentary retinal degeneration (HP:0001146) | 2.29734930 |
66 | Severe visual impairment (HP:0001141) | 2.29369139 |
67 | Cellular immunodeficiency (HP:0005374) | 2.28392181 |
68 | Recurrent sinusitis (HP:0011108) | 2.28162291 |
69 | Hypoalbuminemia (HP:0003073) | 2.28161436 |
70 | Abnormal albumin level (HP:0012116) | 2.28161436 |
71 | Stomach cancer (HP:0012126) | 2.27204143 |
72 | Retrobulbar optic neuritis (HP:0100654) | 2.22155246 |
73 | Optic neuritis (HP:0100653) | 2.22155246 |
74 | Agammaglobulinemia (HP:0004432) | 2.20644436 |
75 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.20509071 |
76 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.19545097 |
77 | Chronic sinusitis (HP:0011109) | 2.18283240 |
78 | Amyotrophic lateral sclerosis (HP:0007354) | 2.18036197 |
79 | Hemoptysis (HP:0002105) | 2.17494300 |
80 | Hemiplegia (HP:0002301) | 2.17447554 |
81 | Hypoproteinemia (HP:0003075) | 2.17157231 |
82 | Increased muscle lipid content (HP:0009058) | 2.16555795 |
83 | Recurrent skin infections (HP:0001581) | 2.15710669 |
84 | Hepatocellular necrosis (HP:0001404) | 2.13796259 |
85 | Mediastinal lymphadenopathy (HP:0100721) | 2.12943075 |
86 | Abnormality of oral frenula (HP:0000190) | 2.12534479 |
87 | Keratoconjunctivitis (HP:0001096) | 2.09956872 |
88 | Radial bowing (HP:0002986) | 2.07370930 |
89 | Colon cancer (HP:0003003) | 2.07150247 |
90 | 11 pairs of ribs (HP:0000878) | 2.05551753 |
91 | Orchitis (HP:0100796) | 2.05395792 |
92 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03176716 |
93 | Vasculitis (HP:0002633) | 2.02141109 |
94 | Increased mean platelet volume (HP:0011877) | 2.00161721 |
95 | T lymphocytopenia (HP:0005403) | 10.0534799 |
96 | Increased IgE level (HP:0003212) | 1.99271576 |
97 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.95828136 |
98 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.95828136 |
99 | Obstructive lung disease (HP:0006536) | 1.95731845 |
100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95731845 |
101 | Epistaxis (HP:0000421) | 1.92250960 |
102 | Amaurosis fugax (HP:0100576) | 1.91789095 |
103 | Inflammation of the large intestine (HP:0002037) | 1.91711692 |
104 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91581771 |
105 | Pulmonary infiltrates (HP:0002113) | 1.89672871 |
106 | Gastrointestinal inflammation (HP:0004386) | 1.87808246 |
107 | Abnormality of the alveolar ridges (HP:0006477) | 1.87607667 |
108 | Renal cortical cysts (HP:0000803) | 1.86722353 |
109 | Pulmonary embolism (HP:0002204) | 1.84861258 |
110 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.82503861 |
111 | Recurrent bacterial skin infections (HP:0005406) | 1.82492623 |
112 | Abnormality of the pleura (HP:0002103) | 1.81646839 |
113 | Trigonocephaly (HP:0000243) | 1.81416544 |
114 | Acute necrotizing encephalopathy (HP:0006965) | 1.81391736 |
115 | IgA deficiency (HP:0002720) | 1.79441571 |
116 | Reticulocytopenia (HP:0001896) | 1.78453253 |
117 | Bicuspid aortic valve (HP:0001647) | 1.78392860 |
118 | Abnormality of the thymus (HP:0000777) | 1.77546785 |
119 | Arterial thrombosis (HP:0004420) | 1.77506932 |
120 | Ureteral stenosis (HP:0000071) | 1.74537451 |
121 | Chest pain (HP:0100749) | 1.71715067 |
122 | Hepatitis (HP:0012115) | 1.71097540 |
123 | Bronchiectasis (HP:0002110) | 1.70881277 |
124 | Hepatic necrosis (HP:0002605) | 1.69932152 |
125 | Abnormal number of erythroid precursors (HP:0012131) | 1.69857097 |
126 | Abnormal foot bone ossification (HP:0010675) | 1.69739910 |
127 | Decreased central vision (HP:0007663) | 1.69015959 |
128 | Broad palm (HP:0001169) | 1.68688569 |
129 | Alkalosis (HP:0001948) | 1.68672403 |
130 | Periodontitis (HP:0000704) | 1.68294035 |
131 | Petechiae (HP:0000967) | 1.68050075 |
132 | Volvulus (HP:0002580) | 1.67607197 |
133 | Ureteral obstruction (HP:0006000) | 1.67501963 |
134 | Acute hepatic failure (HP:0006554) | 1.66928377 |
135 | Pulmonary fibrosis (HP:0002206) | 1.66158413 |
136 | Prolonged bleeding time (HP:0003010) | 1.65921496 |
137 | Increased CSF lactate (HP:0002490) | 1.63670566 |
138 | Abnormality of the pericardium (HP:0001697) | 1.61946811 |
139 | Pancreatitis (HP:0001733) | 1.60188191 |
140 | Type I transferrin isoform profile (HP:0003642) | 1.60180836 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.13120040 |
2 | MAP4K1 | 5.90246229 |
3 | ITK | 3.86250584 |
4 | BCKDK | 3.58324526 |
5 | ZAP70 | 3.31610373 |
6 | STK10 | 2.98074649 |
7 | TAOK3 | 2.96646551 |
8 | NLK | 2.68117979 |
9 | JAK3 | 2.55163707 |
10 | GRK6 | 2.50713289 |
11 | MST4 | 2.50546367 |
12 | FGFR4 | 2.41988986 |
13 | TYK2 | 2.22213446 |
14 | SCYL2 | 2.10812727 |
15 | TESK1 | 2.08971495 |
16 | IKBKE | 2.06075428 |
17 | LCK | 2.03618347 |
18 | TEC | 2.00274675 |
19 | CSK | 1.74940237 |
20 | MAP3K11 | 1.71939114 |
21 | MAP3K14 | 1.71528489 |
22 | SYK | 1.68208824 |
23 | FGFR3 | 1.68124051 |
24 | EEF2K | 1.60864744 |
25 | JAK1 | 1.54123688 |
26 | LRRK2 | 1.53103512 |
27 | NME2 | 1.52620795 |
28 | CLK1 | 1.50792937 |
29 | BTK | 1.46595326 |
30 | MAP3K13 | 1.44659067 |
31 | PINK1 | 1.43995370 |
32 | CAMKK1 | 1.42954847 |
33 | PKN2 | 1.36940686 |
34 | HCK | 1.35029583 |
35 | PRKCH | 1.33286612 |
36 | MAP3K10 | 1.26573776 |
37 | PRKCQ | 1.26320599 |
38 | STK16 | 1.25959955 |
39 | LIMK1 | 1.24249917 |
40 | MAPKAPK3 | 1.21941275 |
41 | PIK3CA | 1.14656352 |
42 | MAP3K7 | 1.07239007 |
43 | CAMKK2 | 1.06396381 |
44 | TBK1 | 1.06289641 |
45 | ADRBK2 | 1.05261592 |
46 | GRK1 | 1.00920209 |
47 | MARK3 | 0.97894720 |
48 | TAOK1 | 0.95187569 |
49 | PRPF4B | 0.94047906 |
50 | PIM1 | 0.93623531 |
51 | BUB1 | 0.90009987 |
52 | MELK | 0.88970279 |
53 | BLK | 0.87551874 |
54 | TESK2 | 0.82395557 |
55 | VRK2 | 0.79548655 |
56 | RIPK4 | 0.78960674 |
57 | LYN | 0.76479314 |
58 | TIE1 | 0.76119387 |
59 | PASK | 0.75654528 |
60 | SIK2 | 0.75434881 |
61 | FES | 0.74941068 |
62 | KDR | 0.73184206 |
63 | PDGFRB | 0.71904475 |
64 | MAPK7 | 0.69849350 |
65 | STK4 | 0.69416415 |
66 | JAK2 | 0.69108473 |
67 | IKBKB | 0.69097677 |
68 | CDK4 | 0.67713575 |
69 | MAP3K3 | 0.66653046 |
70 | RPS6KB2 | 0.64694907 |
71 | RPS6KA4 | 0.63629108 |
72 | TSSK6 | 0.62341706 |
73 | FGFR2 | 0.61198457 |
74 | FYN | 0.60454891 |
75 | FGFR1 | 0.60331153 |
76 | CDC7 | 0.59884077 |
77 | NUAK1 | 0.57825628 |
78 | KIT | 0.56161462 |
79 | MARK2 | 0.55855609 |
80 | INSR | 0.55855543 |
81 | INSRR | 0.55807203 |
82 | CSF1R | 0.55746024 |
83 | TYRO3 | 0.54244851 |
84 | MAPK15 | 0.51676724 |
85 | GRK7 | 0.51310054 |
86 | NEK6 | 0.50291423 |
87 | IRAK4 | 0.50176998 |
88 | VRK1 | 0.49937302 |
89 | SIK3 | 0.49294250 |
90 | MAPK12 | 0.48186347 |
91 | TGFBR1 | 0.47655464 |
92 | ROCK1 | 0.47312398 |
93 | OBSCN | 0.47211499 |
94 | FLT3 | 0.46368240 |
95 | IGF1R | 0.46160506 |
96 | DAPK1 | 0.46019703 |
97 | MAP3K12 | 0.45531153 |
98 | RPS6KA5 | 0.45268427 |
99 | MAP2K6 | 0.44714272 |
100 | ALK | 0.44013594 |
101 | FRK | 0.43967375 |
102 | PDK1 | 0.43801750 |
103 | TGFBR2 | 0.43654442 |
104 | HIPK2 | 0.43068032 |
105 | EPHB1 | 0.43020871 |
106 | TAOK2 | 0.42267895 |
107 | CDK12 | 0.41964929 |
108 | PIK3CG | 0.41617805 |
109 | TNK2 | 0.41172354 |
110 | CDK9 | 0.40843471 |
111 | CDK6 | 0.38306554 |
112 | MYLK | 0.36730275 |
113 | MAP3K5 | 0.36690981 |
114 | PRKCA | 0.36077087 |
115 | TRIB3 | 0.35706764 |
116 | MAPK4 | 0.35468446 |
117 | MAP4K2 | 0.35348402 |
118 | RPS6KA6 | 0.34174550 |
119 | TRPM7 | 0.34157807 |
120 | WNK4 | 0.33025027 |
121 | ACVR1B | 0.32653911 |
122 | CHUK | 0.31867243 |
123 | MATK | 0.30825383 |
124 | EPHA3 | 0.29591690 |
125 | MAPK11 | 0.29431230 |
126 | MAPK3 | 0.29137220 |
127 | MUSK | 0.28429358 |
128 | ILK | 0.28220703 |
129 | OXSR1 | 0.27847734 |
130 | PTK6 | 0.27464233 |
131 | CDK19 | 0.27238999 |
132 | RPS6KC1 | 0.27165515 |
133 | RPS6KL1 | 0.27165515 |
134 | CDK8 | 0.26495310 |
135 | MAP3K8 | 0.25026122 |
136 | EIF2AK3 | 0.24422988 |
137 | BRD4 | 0.23562004 |
138 | PRKACA | 0.23142619 |
139 | MAPK13 | 0.22787350 |
140 | CAMK2A | 0.22368453 |
141 | PAK1 | 0.21373378 |
142 | TLK1 | 0.21363750 |
143 | PRKCB | 0.21167666 |
144 | EGFR | 0.21077485 |
145 | RAF1 | 0.20388590 |
146 | MAPK9 | 0.20374529 |
147 | SRPK1 | 0.19758552 |
148 | TTN | 0.19701160 |
149 | PRKD2 | 0.19228298 |
150 | ARAF | 0.18107338 |
151 | ERBB3 | 0.18036276 |
152 | ROCK2 | 0.16930528 |
153 | AURKA | 0.16386014 |
154 | PRKCD | 0.16243309 |
155 | MAPKAPK2 | 0.16147089 |
156 | SRC | 0.15555627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.47409523 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.69008726 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.56998538 |
4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.45930355 |
5 | Measles_Homo sapiens_hsa05162 | 2.92434537 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.84587621 |
7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.79599076 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.67243828 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.49052866 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23757489 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23189538 |
12 | Ribosome_Homo sapiens_hsa03010 | 2.15545580 |
13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.09190286 |
14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98311590 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.89807892 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72922466 |
17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62194580 |
18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62029964 |
19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55275990 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52865954 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50198222 |
22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49703127 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47412613 |
24 | RNA polymerase_Homo sapiens_hsa03020 | 1.44996253 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39918571 |
26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.34141504 |
27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33368194 |
28 | Colorectal cancer_Homo sapiens_hsa05210 | 1.33298335 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31192332 |
30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29769722 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29689781 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27587920 |
33 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20010963 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.19048679 |
35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17966413 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16769606 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15611816 |
38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13416041 |
39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10206319 |
40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.08876286 |
41 | Spliceosome_Homo sapiens_hsa03040 | 1.08573807 |
42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04274386 |
43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00404561 |
44 | Shigellosis_Homo sapiens_hsa05131 | 0.97744167 |
45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96189966 |
46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95594207 |
47 | Phototransduction_Homo sapiens_hsa04744 | 0.95538539 |
48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93408990 |
49 | DNA replication_Homo sapiens_hsa03030 | 0.91047347 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90791196 |
51 | Influenza A_Homo sapiens_hsa05164 | 0.89371484 |
52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88448183 |
53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86847503 |
54 | Mismatch repair_Homo sapiens_hsa03430 | 0.85792517 |
55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83158922 |
56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82787375 |
57 | Protein export_Homo sapiens_hsa03060 | 0.80800802 |
58 | Apoptosis_Homo sapiens_hsa04210 | 0.80651697 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.78623553 |
60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78464290 |
61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78308749 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78189252 |
63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78085281 |
64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77702634 |
65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74310210 |
66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73105199 |
67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70405062 |
68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68486347 |
69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67800692 |
70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.64816253 |
71 | Hepatitis C_Homo sapiens_hsa05160 | 0.64159775 |
72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61102317 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.59603279 |
74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59520988 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59119057 |
76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57891071 |
77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57226396 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56682814 |
79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55866535 |
80 | Peroxisome_Homo sapiens_hsa04146 | 0.55384732 |
81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55244896 |
82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55009028 |
83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53162238 |
84 | Base excision repair_Homo sapiens_hsa03410 | 0.52084156 |
85 | Proteasome_Homo sapiens_hsa03050 | 0.51181797 |
86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50972700 |
87 | Prostate cancer_Homo sapiens_hsa05215 | 0.50132356 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48601579 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47337301 |
90 | Salmonella infection_Homo sapiens_hsa05132 | 0.46022629 |
91 | Tuberculosis_Homo sapiens_hsa05152 | 0.45658148 |
92 | RNA degradation_Homo sapiens_hsa03018 | 0.45341271 |
93 | Adherens junction_Homo sapiens_hsa04520 | 0.44841291 |
94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44837733 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43845082 |
96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43634366 |
97 | Asthma_Homo sapiens_hsa05310 | 0.43321378 |
98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42884764 |
99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42805224 |
100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42733521 |
101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42055160 |
102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41918833 |
103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40933791 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40916274 |
105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40861283 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40817240 |
107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40202715 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40113846 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.39683520 |
110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38217563 |
111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37724312 |
112 | Malaria_Homo sapiens_hsa05144 | 0.35910573 |
113 | Pertussis_Homo sapiens_hsa05133 | 0.34975436 |
114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34727700 |
115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34173205 |
116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33933647 |
117 | Homologous recombination_Homo sapiens_hsa03440 | 0.33178512 |
118 | Cell cycle_Homo sapiens_hsa04110 | 0.33074247 |
119 | RNA transport_Homo sapiens_hsa03013 | 0.32090798 |
120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30200418 |
121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23944233 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22052983 |
123 | Purine metabolism_Homo sapiens_hsa00230 | 0.22015275 |
124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21719494 |
125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.21578432 |
126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20818143 |
127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20752039 |
128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20171218 |
129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18958767 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18788769 |
131 | Insulin resistance_Homo sapiens_hsa04931 | 0.18483308 |
132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18441280 |
133 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17998578 |
134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17598247 |
135 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17452190 |
136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17219364 |
137 | Alcoholism_Homo sapiens_hsa05034 | 0.12455988 |
138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11603295 |
139 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.10773146 |
140 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10358588 |
141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.10321237 |
142 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.09386544 |
143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09353947 |